Gustave F. Perna
Search results
Moncef Mohamed Slaoui (English: / ˈ m ɒ n s ɪ f ˈ s l aʊ. i /; French: [mɔ̃sɛf slawi]; Moroccan Arabic: منصف السلاوي, IPA: [ˈmonsˤəf ˈsːlæwi]; born July 22, 1959) is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.
Mar 24, 2021 · By Gina Kolata. March 24, 2021. GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Moncef Slaoui, the former head of Operation Warp Speed, from his position as ...
Oct 12, 2023 · On a chilly day in mid-April 2020, Moncef Slaoui, the retired head of the vaccine department at the pharmaceutical giant GlaxoSmithKline, was sitting by his unopened pool in Gladwyne,...
The decision puzzled immunologist Moncef Slaoui, scientific head of Warp Speed, but he attributes it to a word he says with disdain: politics. Slaoui recently resigned from his post, but has agreed to help the Biden transition team into February.
- The Right One For The Job
- Political Activist to Pharmaceutical Executive
- Getting to The Finish Line
- Getting Americans to Buy in
- GeneratedCaptionsTabForHeroSec
Slaoui didn't seek out the co-leader post. He is "not aligned with this administration," he said, and detestspolitics. "I am disappointed with how nasty and unprincipled it has become," he said. But when the Trump administration went looking for someone who could run an unparalleled vaccine development effort, Slaoui's name came up again and again....
Slaoui's journey began duringhis university days in Belgium in the 1970s, when he fell in love with immunology. Hewas born in 1959 in Morocco into a family that believed strongly in education. "Both my father and mother had as their No. 1 objective education," Slaoui said, "which comes with fairness, with values, with helping other people." His fat...
Slaoui has been criticized for being a successful businessman in a government role. He owns about $10 million in GSK stock, amassed over his career. Someday, he plans to retire and live off those dividends, he said, though he admits he's not the retiring type. He's pledged to donate to research any money the stock gains in value while he's working ...
One thing Slaoui can't control is public opinion. That's largely why he toured the Temple University Hospital clinical trial site Nov. 20 and Emory University Hospital the week before that: to get a sense of the challenges of recruiting for the trials and to encourage people to participate. "Thank you so much for (offering) your body for science," ...
Moncef Slaoui, a retired vaccine developer and pharmaceutical executive, helped guide the US government's rapid development and distribution of COVID-19 vaccines and treatments. He toured clinical trial sites, met with researchers and volunteers, and predicted a safe and effective vaccine by year's end.
Mar 24, 2021 · GSK has dismissed its former research boss Moncef Slaoui, who became US national vaccine chief under Donald Trump, after an independent investigation found that he sexually harassed one of its...
People also ask
Who is Dr Moncef Slaoui?
Who is Moncef Mohamed Slaoui?
Is Moncef Slaoui a conflict of interest?
Who is Dr Slaoui & why did he join operation warp speed?
Sep 3, 2020 · NPR's Mary Louise Kelly talks with Moncef Slaoui, chief adviser for the coronavirus vaccine development program, Operation Warp Speed, about the status of vaccines in the U.S.
